Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMY
Recent news which mentions BMY
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
Tickers
ABBV
ALNY
BMY
GILD
Tags
Biotech
Large Cap
BMY
From
Benzinga
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
November 06, 2024
Tickers
BMY
NEWS
NVO
TEVA
Tags
TEVA
Health Care
BMY
From
Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
November 04, 2024
Tickers
BMY
MRK
NEWS
SMMT
Tags
General
Movers
Price Target
From
Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
November 04, 2024
Tickers
BMY
Tags
BMY
Benzinga
Short Sellers
From
Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
November 01, 2024
Tickers
BMY
NEWS
Tags
Top Stories
Analyst Color
Expert Ideas
From
Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
Tickers
AAPL
AMGN
AMZN
BKNG
Tags
Pro Project
CVNA
ETFs
From
Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
October 31, 2024
Tickers
BMY
Tags
Market News
BMY
Recent Press Releases
From
Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
October 31, 2024
Tickers
BMY
NEWS
Tags
BMY
Health Care
Biotech
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
Health Care
BMY
Biotech
From
Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
October 30, 2024
Tickers
BMY
GILD
LYEL
NEWS
Tags
AG Ashley Moody
Penny Stocks
Benzinga
From
Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
October 23, 2024
Tickers
BMY
Tags
Market News
Markets
BZI/UOA
From
Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
October 23, 2024
Tickers
BMY
IBRX
MRK
NEWS
Tags
Briefs
News
Movers
From
Benzinga
Why Is Evotec Stock Gaining Today?
October 23, 2024
Tickers
BMY
EVO
NEWS
Tags
General
Movers
News
From
Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
October 17, 2024
Tickers
ALMS
BMY
NEWS
TAK
Tags
Biotech
BMY
Health Care
From
Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
October 16, 2024
Tickers
BMY
JNJ
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
October 11, 2024
Tickers
BMY
CATX
NEWS
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
October 07, 2024
Tickers
BMY
NEWS
RVPH
Tags
Biotech
Health Care
BMY
From
Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
October 07, 2024
Tickers
BMY
Tags
BZI/AAR
BMY
Benzinga
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Tickers
BMY
ELV
HIMS
HUM
Tags
SAVA
ZTS
MRNA
From
Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
October 07, 2024
Tickers
AAPL
AI
BMY
GILD
Tags
AI
AAPL
ETFs
From
Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
October 07, 2024
Tickers
BMY
CRM
PFE
Tags
Market News
Pro Project
Trading Ideas
From
Benzinga
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
October 04, 2024
Tickers
BMY
NEWS
Tags
Health Care
General
BMY
From
Benzinga
2 Passive-Income Stocks to Load Up On in October
October 03, 2024
Tickers
BMY
LMT
Tags
Market News
BMY
Recent Press Releases
From
Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
October 01, 2024
Tickers
BMY
Tags
BZI/UOA
Markets
Market News
From
Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
October 01, 2024
Tickers
BMY
IGMS
NEWS
Tags
BMY
Health Care
Biotech
From
Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
September 30, 2024
Tickers
BMY
PRME
Tags
Market News
Recent Press Releases
BMY
From
Motley Fool
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
September 30, 2024
Tickers
BMY
NEWS
PRME
Tags
Biotech
Large Cap
Equities
From
Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
Tickers
BMY
MRNA
PFE
Tags
MRNA
Market News
Recent Press Releases
From
Motley Fool
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Tickers
ABBV
BMY
NEWS
Tags
Expert Ideas
Analyst Color
Top Stories
From
Benzinga
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
September 27, 2024
Tickers
BABA
BHP
BMY
BP
Tags
Markets
MU
Stories That Matter
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.